ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 72 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q4 2017. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $3,349,000 | +62.6% | 408,901 | -10.9% | 0.01% | +60.0% |
| Q2 2017 | $2,060,000 | -22.7% | 458,901 | -5.2% | 0.01% | -28.6% |
| Q1 2017 | $2,666,000 | +23.3% | 483,901 | -9.4% | 0.01% | +16.7% |
| Q4 2016 | $2,162,000 | -73.5% | 533,901 | -53.9% | 0.01% | -72.7% |
| Q3 2016 | $8,157,000 | -35.4% | 1,157,049 | -25.4% | 0.02% | -35.3% |
| Q2 2016 | $12,633,000 | +35.1% | 1,550,000 | +34.8% | 0.03% | +36.0% |
| Q1 2016 | $9,350,000 | -8.8% | 1,150,000 | +35.3% | 0.02% | -7.4% |
| Q4 2015 | $10,251,000 | +144.7% | 850,000 | +142.9% | 0.03% | +125.0% |
| Q3 2015 | $4,190,000 | -23.8% | 350,000 | +16.7% | 0.01% | -14.3% |
| Q2 2015 | $5,499,000 | – | 300,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 15,832,611 | $68,080,000 | 3.54% |
| Matrix Capital Management Company, LP | 28,000,000 | $120,400,000 | 3.21% |
| Virtus ETF Advisers LLC | 50,655 | $218,000 | 0.46% |
| TFG Asset Management GP Ltd | 500,000 | $2,150,000 | 0.27% |
| Rock Springs Capital Management LP | 800,000 | $3,440,000 | 0.13% |
| Orbimed Advisors | 1,350,655 | $5,808,000 | 0.09% |
| Vident Investment Advisory, LLC | 289,340 | $1,244,000 | 0.07% |
| WS MANAGEMENT LLLP | 185,537 | $798,000 | 0.05% |
| Rathbones Group PLC | 285,722 | $1,229,000 | 0.04% |
| Tekla Capital Management LLC | 228,496 | $983,000 | 0.04% |